Display Settings:

Format
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 4

    1.

    Glucagon-like peptide-1, diabetes, and cognitive decline: possible pathophysiological links and therapeutic opportunities.

    Mossello E, Ballini E, Boncinelli M, Monami M, Lonetto G, Mello AM, Tarantini F, Baldasseroni S, Mannucci E, Marchionni N.

    Exp Diabetes Res. 2011;2011:281674. doi: 10.1155/2011/281674. Epub 2011 Jun 1. Review.

    PMID:
    21747826
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study.

    Pozzi C, Lapi F, Mazzaglia G, Inzitari M, Boncinelli M, Geppetti P, Mugelli A, Marchionni N, Di Bari M.

    Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):954-60. doi: 10.1002/pds.1997.

    PMID:
    20623521
    [PubMed - indexed for MEDLINE]
    3.

    Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease?

    Mossello E, Boncinelli M, Caleri V, Cavallini MC, Palermo E, Di Bari M, Tilli S, Sarcone E, Simoni D, Biagini CA, Masotti G, Marchionni N.

    Dement Geriatr Cogn Disord. 2008;25(4):372-9. doi: 10.1159/000121334. Epub 2008 Mar 20.

    PMID:
    18354253
    [PubMed - indexed for MEDLINE]
    4.

    Mini-Mental State Examination: a 30-year story.

    Mossello E, Boncinelli M.

    Aging Clin Exp Res. 2006 Aug;18(4):271-3.

    PMID:
    17063061
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk